Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.2. Drivers
4.2.1. Increasing Number of ESRD Patients
4.2.2. Increasing Prevalence of Hypertension and Diabetes
4.3. Restraints
4.3.1. Risks and Complications Associated with Dialysis
4.4. Opportunity
4.5. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces Analysis
5.2. Regulatory Analysis
5.3. Supply Chain Analysis
5.4. Pricing Analysis
5.5. Unmet Needs
6. By Type
6.1. Introduction
6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), by Type
6.1.2. Market Attractiveness Index, by Type
6.2. Hemodialysis
6.2.1. Introduction
6.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
6.3. Peritoneal Dialysis
7. By End User
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), by End User
7.1.2. Market Attractiveness Index, by End User
7.2. Hospitals
7.2.1. Introduction
7.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
7.3. Dialysis Centers
7.4. Homecare
7.5. Others
8. By Region
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
8.1.2. Market Attractiveness Index, By Region
8.2. North America
8.2.1. Introduction
8.2.2. Key Region-Specific Dynamics
8.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
8.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
8.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Countries
8.2.5.1. U.S.
8.2.5.2. Canada
8.2.5.3. Mexico
8.3. Europe
8.3.1. Introduction
8.3.2. Key Region-Specific Dynamics
8.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
8.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
8.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Countries
8.3.5.1. Germany
8.3.5.2. U.K.
8.3.5.3. France
8.3.5.4. Italy
8.3.5.5. Spain
8.3.5.6. Rest of Europe
8.4. South America
8.4.1. Introduction
8.4.2. Key Region-Specific Dynamics
8.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
8.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
8.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), by Countries
8.4.5.1. Brazil
8.4.5.2. Argentina
8.4.5.3. Rest of South America
8.5. Asia Pacific
8.5.1. Introduction
8.5.2. Key Region-Specific Dynamics
8.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
8.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
8.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), by Countries
8.5.5.1. China
8.5.5.2. India
8.5.5.3. Japan
8.5.5.4. Australia
8.5.5.5. Rest of Asia Pacific
8.6. Middle East and Africa
8.6.1. Introduction
8.6.2. Key Region-Specific Dynamics
8.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
8.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
9. Competitive Landscape
9.1. Competitive Scenario
9.2. Competitor Strategy Analysis
9.3. Comparative Product Portfolio Analysis
9.4. Market Positioning/Share Analysis
9.5. Mergers and Acquisitions Analysis
10. Company Profiles
10.1. Baxter International Inc.
10.1.1. Company Overview
10.1.2. Product Portfolio and Description
10.1.3. Key Highlights
10.1.4. Financial Overview
10.2. B. Braun Melsungen AG
10.3. Becton, Dickinson and Company
10.4. Cantel Medical Corporation
10.5. Davita Inc.
10.6. Diaverum
10.7. Dialife Group
10.8. Nipro Corporation
10.9. Isopure Corp
10.10. Medtronic PLC
LIST NOT EXHAUSTIVE
11. Global Dialysis Market – DataM
11.1. Appendix
11.2. About Us and Method of Fixation
11.3. Contact Us